Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing Spondylitis

NCT00762463 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Ankylosing Spondylitis

Interventions

DRUG: Celecoxib
DRUG: Diclofenac SR

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.